FDA Approved: NYSTATIN CREAM — Original Application (Crown Laboratories)

View source ↗

Summary

FDA approves Crown Laboratories' Nystatin Cream as an original generic topical antifungal (ANDA 207733) indicated for candidiasis, including skin infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Cutaneous Candidiasis

Drugs mentioned

• Nystatin Cream (nystatin)

Snippet

ORIG AP for NYSTATIN CREAM (NYSTATIN CREAM)